Deutsche Bank’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $185K | Buy |
+22,328
| New | +$185K | ﹤0.01% | 2999 |
|
|
2024
Q4 | – | Sell |
-12,313
| Closed | -$61.6K | – | 3573 |
|
|
2024
Q3 | $61.6K | Hold |
12,313
| – | – | ﹤0.01% | 3275 |
|
|
2024
Q2 | $75.2K | Hold |
12,313
| – | – | ﹤0.01% | 3173 |
|
|
2024
Q1 | $137K | Buy |
12,313
+1,002
| +9% | +$11.1K | ﹤0.01% | 2987 |
|
|
2023
Q4 | $127K | Buy |
+11,311
| New | +$127K | ﹤0.01% | 3067 |
|
|
2021
Q3 | – | Sell |
-3,068
| Closed | -$22K | – | 4278 |
|
|
2021
Q2 | $22K | Sell |
3,068
-12,133
| -80% | -$87K | ﹤0.01% | 4250 |
|
|
2021
Q1 | $95K | Sell |
15,201
-1,326
| -8% | -$8.29K | ﹤0.01% | 3932 |
|
|
2020
Q4 | $123K | Buy |
16,527
+4,302
| +35% | +$32K | ﹤0.01% | 3659 |
|
|
2020
Q3 | $74K | Buy |
12,225
+1,051
| +9% | +$6.36K | ﹤0.01% | 3625 |
|
|
2020
Q2 | $93K | Buy |
+11,174
| New | +$93K | ﹤0.01% | 3416 |
|
|
2020
Q1 | – | Sell |
-1,393
| Closed | -$9K | – | 4225 |
|
|
2019
Q4 | $9K | Buy |
+1,393
| New | +$9K | ﹤0.01% | 4301 |
|
|
2019
Q3 | – | Sell |
-2,810
| Closed | -$11K | – | 4647 |
|
|
2019
Q2 | $11K | Sell |
2,810
-43,331
| -94% | -$170K | ﹤0.01% | 4570 |
|
|
2019
Q1 | $222K | Buy |
46,141
+31,073
| +206% | +$150K | ﹤0.01% | 3855 |
|
|
2018
Q4 | $95K | Sell |
15,068
-11,214
| -43% | -$70.7K | ﹤0.01% | 4082 |
|
|
2018
Q3 | $215K | Sell |
26,282
-3,461
| -12% | -$28.3K | ﹤0.01% | 4103 |
|
|
2018
Q2 | $310K | Buy |
29,743
+932
| +3% | +$9.71K | ﹤0.01% | 3994 |
|
|
2018
Q1 | $348K | Buy |
28,811
+28,207
| +4,670% | +$341K | ﹤0.01% | 3831 |
|
|
2017
Q4 | $6K | Buy |
604
+599
| +11,980% | +$5.95K | ﹤0.01% | 4335 |
|
|
2017
Q3 | $0 | Buy |
+5
| New | – | ﹤0.01% | 4390 |
|